(CAMBRIDGE, MA) NOV 17 – A CAMBRIDGE, MASSACHUSETTS PHARMACEUTICAL COMPANY HAS COME UP WITH A DRUG IT BELIEVES CAN PROLONG THE LIVES OF VICTIMS SUFFERING THE TYPE OF BRAIN CANCER THAT KILLED MASSACHUSETTS SENATOR EDWARD KENNEDY.
FOX NEWS RADIO’S BILL MARCUS HAS MORE.
DECIPHERA IS NOW IN PHASE ONE ITS TRIALS. DECIPHERA C-E-O MICHAEL TAYLOR SAYS HIS COMPANY’S GOAL IS TO EXTEND PATIENTS LIVES BY SEVERAL MONTHS, IF NOT MORE.
***
DECIPHERA PHARMACEUTICALS CHIEF SCIENCE OFFICER DAN FLYNN SAYS ALTIRANTINIB WILL KEEP GLIOBLASTOMA BRAIN TUMORS FROM EXPLODING AND INVADING OTHER PARTS OF THE BRAIN.